| Serial Number | 86605899 |
| Word Mark | MEDIGENE IMMUNOTHERAPIES |
| Filing Date | Wednesday, April 22, 2015 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, March 24, 2023 |
| Registration Number | 5038910 |
| Registration Date | Tuesday, September 13, 2016 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 28, 2016 |
| Goods and Services | Medicines for humans and animals for the treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, vaccines, medicated serums for treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, diagnostic and drug testing kits comprised of medical reagents and assays for testing of bodily fluids for use in disease detection, namely, tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, all prepared by means of molecular biology, genetic engineering or biotechnological methods; substances for medical diagnosis purposes, namely, proteins, nucleic acids, cell products, protein conjugates, peptides, enzymes and enzyme preparations, particularly antibodies and T cell proteins; T cells, dendritic cells, and other cells of the immune system, viruses, and virus-like particles, all for medical purposes; liposomes for medical purposes; plant extracts for medical purposes; low molecular active ingredients, namely, medicines for the treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, vaccines, adjuvants, serums for treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, diagnostic and drug testing kits comprised of medical reagents and assays that test for the presence of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, autoimmune diseases and immune therapy |
| Pseudo Mark | MEDIGENE IMMUNO THERAPIES |
| Goods and Services | Licensing of intellectual property, including trademarks and patents in the field of biotechnology, pharmacy, and medicine |
| Goods and Services | Medical analyses and medical consultancy in the context of the treatment of single persons, particularly in the field of tumor precursors, benign and malignant tumor diseases, autoimmune diseases and immunotherapy |
| Disclaimer with Predetermined Text | "IMMUNOTHERAPIES" |
| Goods and Services | Services of a molecular biology or biotechnology laboratory, particularly research and development work in the field of human medical and veterinary medical diagnosis and therapy by means of molecular biology, genetic engineering or biotechnological methods as well as in the field of screening for pharmaceutically active compounds; design and development of test methods and test kits in the field of biotechnology and medicine |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 24, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 24, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 24, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 24, 2023 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Medigene Immunotherapies GmbH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Planegg/Martinsried DE |
| Party Name | Medigene Immunotherapies GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Planegg/Martinsried DE |
| Party Name | Medigene Immunotherapies GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Planegg/Martinsried DE |
| Event Date | Event Description |
| Friday, March 24, 2023 | CANCELLED SEC. 8 (6-YR) |
| Monday, September 13, 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, September 13, 2016 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 28, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 28, 2016 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 8, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, May 23, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, May 13, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, May 12, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 12, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 6, 2016 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, May 6, 2016 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, May 6, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, December 17, 2015 | ASSIGNED TO EXAMINER |
| Monday, November 9, 2015 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, November 9, 2015 | NON-FINAL ACTION E-MAILED |
| Monday, November 9, 2015 | NON-FINAL ACTION WRITTEN |
| Wednesday, October 21, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 21, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 14, 2015 | ASSIGNED TO LIE |
| Wednesday, September 23, 2015 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Friday, August 7, 2015 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, August 7, 2015 | LETTER OF SUSPENSION E-MAILED |
| Friday, August 7, 2015 | SUSPENSION LETTER WRITTEN |
| Friday, August 7, 2015 | EXAMINER'S AMENDMENT ENTERED |
| Friday, August 7, 2015 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, August 7, 2015 | EXAMINERS AMENDMENT E-MAILED |
| Friday, August 7, 2015 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, July 31, 2015 | ASSIGNED TO EXAMINER |
| Saturday, May 2, 2015 | NOTICE OF PSEUDO MARK E-MAILED |
| Friday, May 1, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, April 25, 2015 | NEW APPLICATION ENTERED |